Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.38 |
| ▸ | GAA | P10253 | 1/20 | 0.38 |
| ▸ | TSHR | P16473 | 1/20 | 0.38 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.38 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.38 |
| ▸ | PDE4B | Q07343 | 8/20 | 0.34 |
| ▸ | PDE4D | Q08499 | 8/20 | 0.34 |
| ▸ | RXRA | P19793 | 3/20 | 0.33 |
| ▸ | NR4A2 | P43354 | 3/20 | 0.33 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.33 |
| ▸ | HPGD | P15428 | 2/20 | 0.33 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.33 |
| ▸ | HCAR2 | Q8TDS4 | 1/20 | 0.33 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8977160 | 0.84 | PDE4B (0.37) | KDM4EGAATSHRSMN1; SMN2HSD17B10 | |
| SCHEMBL8977089 | 0.80 | KDM4E (0.33) | KDM4EGAATSHRSMN1; SMN2HSD17B10 | |
| SCHEMBL8995714 | 0.75 | HCAR2 (0.41) | KDM4EGAAHCAR2 | |
| SCHEMBL28185639 | 0.74 | KDM4E (0.38) | KDM4EGAATSHRSMN1; SMN2HSD17B10 | |
| SCHEMBL8212422 | 0.69 | KDM4E (0.37) | KDM4EGAATSHRSMN1; SMN2HSD17B10 | |
| SCHEMBL8846408 | 0.69 | KDM4E (0.37) | KDM4EGAATSHRSMN1; SMN2HSD17B10 | |
| SCHEMBL3227961 | 0.69 | KDM4E (0.37) | KDM4EGAATSHRSMN1; SMN2HSD17B10 | |
| SCHEMBL9784571 | 0.68 | HCAR2 (0.41) | KDM4EGAAALDH1A1HCAR2 | |
| SCHEMBL16191206 | 0.67 | KDM4E (0.36) | KDM4EGAATSHRSMN1; SMN2HSD17B10 | |
| SCHEMBL8995696 | 0.67 | GABRP (0.37) | TSHRMAPK1ALDH1A1HCAR2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10669254-B2 | Process for preparing methoxy methyl pyridine dicarboxylate | ADAMA AGAN LTD. (IL) | 2020-06-02 | — | — | US | claimed |
| EP-3541787-A1 | PROCESS FOR PREPARING METHOXY METHYL PYRIDINE DICARBOXYLATE | Adama Agan Ltd. (IL) | 2019-09-25 | — | — | EP | claimed |
| US-20190276427-A1 | PROCESS FOR PREPARING METHOXY METHYL PYRIDINE DICARBOXYLATE | ADAMA AGAN LTD. (IL) | 2019-09-12 | — | — | US | claimed |
| WO-2018091964-A1 | PROCESS FOR PREPARING METHOXY METHYL PYRIDINE DICARBOXYLATE | ADAMA AGAN LTD. (IL) | 2018-05-24 | — | — | WO | claimed |
| EP-0461403-B1 | Process for the preparation of dialkyl pyridine-2,3-dicarboxylate and derivatives thereof from dialkyl dichlorosucciante | AMERICAN CYANAMID CO (US) | 1996-08-28 | — | — | EP | claimed |
| EP-0560019-B1 | Process for the preparation of dialkyl 2,3-pyridinedicarboxylate and derivatives thereof from an alpha, beta-unsaturated oxime and an aminobutenedioate | AMERICAN CYANAMID CO (US) | 1996-04-24 | — | — | EP | claimed |
| EP-4001266-A2 | PROCESS FOR PREPARING METHOXY METHYL PYRIDINE DICARBOXYLATE | Adama Agan Ltd. (IL) | 2022-05-25 | — | — | EP | disclosed |
| EP-3782985-A1 | PROCESS FOR MANUFACTURING 5-METHOXYMETHYLPYRIDINE-2,3-DICARBOXYLIC ACID DERIVATIVES | BASF Agrochemical Products B.V. (NL) | 2021-02-24 | — | — | EP | disclosed |
| US-10669254-B2 | Process for preparing methoxy methyl pyridine dicarboxylate | ADAMA AGAN LTD. (IL) | 2020-06-02 | — | — | US | disclosed |
| EP-3541787-A1 | PROCESS FOR PREPARING METHOXY METHYL PYRIDINE DICARBOXYLATE | Adama Agan Ltd. (IL) | 2019-09-25 | — | — | EP | disclosed |
| US-20190276427-A1 | PROCESS FOR PREPARING METHOXY METHYL PYRIDINE DICARBOXYLATE | ADAMA AGAN LTD. (IL) | 2019-09-12 | — | — | US | disclosed |
| WO-2018091964-A1 | PROCESS FOR PREPARING METHOXY METHYL PYRIDINE DICARBOXYLATE | ADAMA AGAN LTD. (IL) | 2018-05-24 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10669254-B2 | Process for preparing methoxy methyl pyridine dicarboxylate | MCCC2, C5, KDM4C | KDM4E 39/4885GAA 4467/4885TSHR 3975/4885 |
| US-20190276427-A1 | PROCESS FOR PREPARING METHOXY METHYL PYRIDINE DICARBOXYLATE | MCCC2, C5, KDM4C | KDM4E 39/4885GAA 4467/4885TSHR 3975/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.